Latest Breaking News On - Kohta satake - Page 1 : comparemela.com

The Worldfolio: News Release: Toward Dissemination of Digital Therapeutics

The Worldfolio: News Release: Toward Dissemination of Digital Therapeutics
theworldfolio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theworldfolio.com Daily Mail and Mail on Sunday newspapers.

Chuo kuKohta satakeNihonbashi kodenma choTeijin pharmaMasaki tanedaTeijin limited corporate communications departmentTeijin groupCompany nameCorporate profile of cureapp incHead office locationHuman solutionsCureapp incTeijin pharma sign agreementJoint marketingPrescription digital therapeutic appPharma limited

CureApp, Inc : CureApp: Digital Therapeutic App for Hypertension Receives Insurance Coverage, Sales of the Service to Medical Institutions Across Japan Launch on September 1

Assisting Lifestyle Changes as a Treatment for Hypertension CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension

Japan generalChuo kuKostenloser wertpapierhandelNihonbashi kodenma choKohta satakeCureapp north america incUs branchNational healthcareCureapp incHead officeSmoking cessation programSawai group holdings coNational hospital organization kurihamaAddiction centerUniversity of tokyo hospitalDevelopment of software

CureApp: Digital Therapeutic App for Hypertension Receives Insurance Coverage, Sales of the Service

Assisting Lifestyle Changes as a Treatment for HypertensionTOKYO (BUSINESS WIRE) #App CureApp, Inc. (Head Office: Chuo-ku, Tokyo; CEO: Kohta Satake) announces the start of insurance coverage for its CureApp HT Hypertension Adjunctive Treatment App (hereafter, CureApp HT), a DTx 1 solution treating hypertension, i.

Japan generalChuo kuNihonbashi kodenma choKohta satakeCureapp north america incUs branchNational healthcareCureapp incHead officeSmoking cessation programSawai group holdings coNational hospital organization kurihamaAddiction centerUniversity of tokyo hospitalDevelopment of softwareHealth guidance

Carlyle to Acquire a Significant Minority Stake in CureApp, a Leading Prescription Digital Therapeutics Provider in Japan

Strategic growth investment in CureApp to support the rollout of its hypertension app and advance its new development pipeline, as digital therapeutics gain traction in Japan.

Lonna leongGenta saitoKazuhiro yamadaKohta satakeCureapp incGlobal investment solutionsSolasto corporationSunsho pharmaceutical coQualicaps coColin medical technologyManaging directorCarlyle japanRepresentative directorColin medicalGlobal private equityGlobal credit

Carlyle to Acquire a Significant Minority Stake in CureApp, a Leading Prescription Digital Therapeutics Provider in Japan

Strategic growth investment in CureApp to support the rollout of its hypertension app and advance its new development pipeline, as digital therapeutics gain traction in Japan

Lonna leongGenta saitoKazuhiro yamadaKohta satakeCureapp incGlobal investment solutionsSolasto corporationSunsho pharmaceutical coQualicaps coColin medical technologyManaging directorCarlyle japanRepresentative directorColin medicalGlobal private equityGlobal credit